A clinical study of MK-1403 in healthy people (MK-1403-002)
MK-1403-002
Phase 1 other active
Quick answer
A clinical study of MK-1403 in healthy people (MK-1403-002) for Atherosclerosis is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Atherosclerosis
- Phase
- Phase 1
- Modality
- other
- Status
- active